Lv11
58 积分 2021-08-31 加入
Activation-induced cell death in CAR-T cell therapy
3天前
已完结
High-efficiency of genetic modification using CRISPR/Cpf1 system for engineered CAR-T cell therapy
5天前
已完结
piggyBac-transposon-mediated CAR-T cells for the treatment of hematological and solid malignancies
10天前
已完结
Challenges in scaling up AAV-based gene therapy manufacturing
21天前
已完结
A highly efficient transgene knock-in technology in clinically relevant cell types
24天前
已完结
“Therapeutic applications of the ‘NPGP’ family of viral 2As”
2个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
3个月前
已完结
Comprehensive UHPLC- and CE-based methods for engineered Cas9 characterization
4个月前
已完结
High-efficiency of genetic modification using CRISPR/Cpf1 system for engineered CAR-T cell therapy
4个月前
已完结
Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
8个月前
已完结
皖公网安备34019202002308
